Application 206197
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | POWDER;INTRAVENOUS | EQ 150MG BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 63323-972 | Fosaprepitant | FOSAPREPITANT | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-972 | Fosaprepitant | FOSAPREPITANT | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-972 | Fosaprepitant | FOSAPREPITANT | Fresenius Kabi USA, LLC | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 19709 | ORIG | 2016-06-13 |
| 32786 | ORIG | 2016-06-10 |